Three more health apps obtained reimbursement in Germany

28

Dec 2021

In December 2021, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 27 health apps are now available at the DiGA Directory.

On December 11, 2021, the health app “HelloBetter Diabetes and Depression” (GET.ON Institute for Online Health Training GmbH, Germany) was introduced. “HelloBetter Diabetes and Depression” is an interactive psychological therapy program aimed to reduce the severity of depressive symptoms in people with type 1 or type 2 diabetes mellitus. In addition to well-founded psychoeducation texts, videos, and audios available for use, the 12-week online course also provides effective cognitive-behavioral therapy (CBT) strategies, including behavioral activation and problem-solving techniques. The health app is available in German with a tariff of €599.

The health app “HelloBetter ratiopharm chronic pain”, developed by the same manufacturer as the abovementioned one, was introduced on December 18, 2021. It is an interactive psychological online program for the sustained reduction of pain impairment in people with chronic pain. In addition to well-founded psychoeducation texts, videos, and audios available for use, the patients can learn effective acceptance and commitment therapy (ACT) strategies, further developing cognitive-behavioral therapy (CBT). “HelloBetter ratiopharm chronic pain” is available in German with the same tariff of €599.

On December 18, 2021, the health app “Kranus Edera” (Kranus Health GmbH, Germany) was introduced. It is a digital health application for the holistic treatment of erectile dysfunction and its causes. The stand-alone therapy supports men with erectile dysfunction actively participating in their treatment. It helps doctors implement the recommendations of the guidelines for the treatment of erectile dysfunction and thus expand the therapy options. The therapy is supplemented by imparting knowledge about the disease and helpful tips, e.g., nutrition and preventive measures. “Kranus Edera” is available in German with a tariff of €552.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

22

Mar 2022

On February 17, 2022, the Federal Joint Committee (G-BA) has decided to include the method of matrix-associated autologous chondrocyte implantation (M-ACI) on the knee joint in the case of symptomatic cartilage damage in the lists of reimbursed procedures in the hospital and ambulatory settings.

Read more

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more